0001728117-23-000052.txt : 20230509 0001728117-23-000052.hdr.sgml : 20230509 20230509161234 ACCESSION NUMBER: 0001728117-23-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230505 FILED AS OF DATE: 20230509 DATE AS OF CHANGE: 20230509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hasnain Faheem CENTRAL INDEX KEY: 0001352620 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 23902130 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_168366312804581.xml FORM 4 X0407 4 2023-05-05 0 0001728117 Gossamer Bio, Inc. GOSS 0001352620 Hasnain Faheem 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 1 1 0 0 President & CEO 0 Stock Option (Right to Buy) 1.36 2023-05-05 4 A 0 750000 0 A 2033-05-04 Common Stock 750000.0 750000 D The Option shall vest and become exercisable as follows: (i) with respect to 50% of the shares subject to the option, the Issuer's common stock achieving a 30-day average stock price at or above $5 per share within four years of the grant date; (ii) with respect to 25% of the shares subject to the option, the Issuer's common stock achieving a 30-day average stock price at or above $7.50 per share within four years of the grant date; and (iii) with respect to the remaining 25% of the shares subject to the option, the Issuer's common stock achieving a 30-day average stock price at or above $10 per share within four years of the grant date; in each case subject to the Reporting Person's continuous service to the Issuer on each such vesting date; provided in no event will any portion of the option vest prior to the first anniversary of the grant date. /s/ Jeff Boerneke, Attorney-in-Fact 2023-05-09